New offerings for the refractive surgeon

Article

The Visante omni is the first system to combine OCT and Placido disk technologies, providing comprehensive anterior and posterior topography for improved patient selection and care.

The Visante omni is the first system to combine OCT and Placido disk technologies, providing comprehensive anterior and posterior topography for improved patient selection and care. Linking two of Carl Zeiss' platforms, the Atlas corneal topographer with Visante OCT), the new Visante omni allows the refractive surgeon to identify pre-existing corneal abnormalities, such as keratoconus, in their earliest stages.

“Combining OCT pachymetry with Placido disk technology may provide the most precise information possible about the back surface of the cornea,” said Jack Holladay, MD, of Holladay Lasik Institute. In addition, the Visante omni Holladay reports, allows physicians to access patient-specific data sets in a simple, one page printout to maximize workflow and practice efficiencies.

The new 500 kHz VisuMax Femtosecond System is said by Zeiss to be more than twice the speed of the 200 kHz system. Treatment times are reduced from approximately 20 - 25 seconds to just ten seconds per eye. Laser spot density is also said to have been increased by approximately 20 per cent, facilitating more consistent flap lifts and smoother stromal beds. The new 500 kHz upgrade works with the existing VisuMax platform with no programming modifications required by the surgeon.

“Clinically, this produces two significant benefits. First, the higher repetition rate reduces the actual laser emission time, which is the critical phase of the procedure. Thus, the patient is required to remain still for a very short amount of time. Secondly, the higher spot density results in even more precise tissue separation,” said Jon Dishler, MD, of Dishler Laser Institute.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.